Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
pulmonary alveolar proteinosis associated with ruxolitinib
Original title: “Pulmonary alveolar proteinosis associated with ruxolitinib.”
pulmonary alveolar proteinosis diagnosed during leuprorelin acetate therapy for ovarian endometrioma a case report
Original title: “Pulmonary alveolar proteinosis diagnosed during leuprorelin acetate therapy for ovarian endometrioma: a case report.”
targeting autoimmune pulmonary alveolar proteinosis with gm csf insights from clinical trials and emerging therapies
Original title: “Targeting autoimmune pulmonary alveolar proteinosis with GM-CSF: insights from clinical trials and emerging therapies.”
inhaled granulocyte macrophage colony stimulating for autoimmune pulmonary alveolar proteinosis from pathogenesis to clinical practice
Original title: “Inhaled granulocyte-macrophage colony-stimulating for autoimmune pulmonary alveolar proteinosis: From pathogenesis to clinical practice.”
pulmonary alveolar proteinosis in greece t rkiye cyprus answers in a real life comparison
Original title: “Pulmonary Alveolar Proteinosis in Greece-Türkiye-Cyprus: Answers in a Real-Life Comparison.”
neurodevelopmental profile of children with mars1 related pulmonary alveolar proteinosis a cohort study
Original title: “Neurodevelopmental Profile of Children With MARS1-Related Pulmonary Alveolar Proteinosis: A Cohort Study.”
secondary pulmonary alveolar proteinosis associated with ruxolitinib after bone marrow transplantation a case with transient improvement following drug discontinuation
Original title: “Secondary Pulmonary Alveolar Proteinosis Associated With Ruxolitinib After Bone-Marrow Transplantation: A Case With Transient Improvement Following Drug Discontinuation.”
targeting the ppar abc transporter axis ameliorates secondary pulmonary alveolar proteinosis induced by indium oxide nanoparticles
Original title: “Targeting the PPAR-γ-ABC transporter axis ameliorates secondary pulmonary alveolar proteinosis induced by indium oxide nanoparticles.”
comorbidity of autoimmune diseases in patients with autoimmune pulmonary alveolar proteinosis
Original title: “Comorbidity of autoimmune diseases in patients with autoimmune pulmonary alveolar proteinosis.”
autoimmune pulmonary alveolar proteinosis induced by brigatinib a case report and literature review
Original title: “[Autoimmune pulmonary alveolar proteinosis induced by brigatinib: a case report and literature review].”
efficacy and safety of inhaled gm csf in autoimmune pulmonary alveolar proteinosis a systematic review and meta analysis of randomized controlled trials
Original title: “Efficacy and Safety of Inhaled GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.”
pleuroparenchymal fibroelastosis complicated by pulmonary alveolar proteinosis after peripheral blood stem cell transplantation
Original title: “Pleuroparenchymal Fibroelastosis Complicated by Pulmonary Alveolar Proteinosis After Peripheral Blood Stem Cell Transplantation.”
Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […] The post Savara’s Early Access Program appeared first on Global Genes.
Original title: “Savara’s Early Access Program”